pharmaceutical investing UroGen Pharma Submits Investigational New Drug (IND) Application for UGN-102 (VesiGel)
Ni-Co Energy Reports 4.60 Metres at 0.59% Nickel at Kremer-2; Phase-One Drilling Advances Magmatic Sulphide Exploration Model